Treatment of small superficial haemangioma with timolol 0.5% ophthalmic solution: A series of 20 cases

Dermatology

Volumn 223, Issue 4, 2012, Pages 330-334

  Oranje, A P ^a,c   Janmohamed, S R ^a   Madern, G C ^b   De Laat, P C J ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b Department of Paediatric Surgery ^*  (Netherlands)

^c Maasstad Hospital Rotterdam   (Netherlands)

Author keywords

Blockers; Facial disfigurement; Haemangioma of infancy, small; Timolol ophthalmic solution 0.5 ; Topical treatment

Indexed keywords

EYE DROPS; PROPRANOLOL; TIMOLOL;

ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; INFANT; INFANT DISEASE; OUTCOME ASSESSMENT; PAPULE; PRIORITY JOURNAL; SKIN DEFECT; SKIN EXAMINATION; SKIN HEMANGIOMA; TUMOR GROWTH; TUMOR REGRESSION;

ADMINISTRATION, TOPICAL; FEMALE; HEMANGIOMA; HUMANS; INFANT; MALE; OPHTHALMIC SOLUTIONS; TIMOLOL;

EID: 84858437413     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000334778     Document Type: Article

References (24)

1. Drolet BA, Esterly NB, Frieden IJ: Hemangiomas in children. N Engl J Med 1999; 341: 173-181.
2. Schwartz RA, Sidor MI, Musumeci ML, Lin RL, Micali G: Infantile haemangiomas: a challenge in paediatric dermatology. J Eur Acad Dermatol Venereol 2010; 24: 631-638.
3. Leaute-Labreze C, Dumas de la Roque E, et al: Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-2651.
4. Sans V, de la Roque ED, Berge J, et al: Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009; 124:e423- 431.
5. Bayliss SJ, Berk DR, Van Hare GF, Balzer D, Yamada K, Lueder G, Lanoel A, de la Fuente V, Cordisco MR: Re: propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol 2010; 27: 319-320.
6. Mishra A, Holmes WJ, Gorst C, Liew SH: Role of propranolol in the management of periocular hemangiomas. Plast Reconstr Surg 2010; 126: 671.
7. Lawley LP, Siegfried E, Todd JL: Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol 2009; 26: 610-614.
8. Holland KE, Frieden IJ, Frommelt PC, et al: Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol 2010; 146: 775-778.
9. Ni N, Wagner RS, Langer P, Guo S: New developments in the management of periocular capillary hemangioma in children. J Pediatr Ophthalmol Strabismus 2011; 48: 269-276.
10. Maguiness SM, Frieden IJ: Current management of infantile hemangiomas. Semin Cutan Med Surg 2010; 29: 106-114.
11. Pandey A, Gangopadhyay AN, Sharma SP, Kumar V, Gupta DK, Gopal SC: Evaluation of topical steroids in the treatment of superficial hemangioma. Skinmed 2010; 8: 9-11.
12. McCuaig CC, Dubois J, Powell J, et al: A phase II open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma. Pediatr Dermatol 2009; 26: 203-212.
13. Guo S, Ni N: Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution. Arch Ophthalmol 2010; 128: 255-256.
14. Pope E, Chakkiiakandiyil A:Topical timolol gel or infantile hemangiomas: a pilot study. Arch Dermatol 2010; 146: 564-565.
15. Bonifazi E, Mazzotta F, Colonna V, et al: Topical propranolol in the superficial infantile hemangioma of the skin. Eur J Pediatr Dermatol 2010; 20: 247-251.
16. Ni N, Wagner PR, Suqin G: Topical timolol for periocular hemangioma: report of further study. Arch Ophthalmol 2011; 129: 377-379.
17. Khunger N, Pahwa M: Dramatic response to topical timolol lotion of a large hemifacial infantile haemangioma associated with PHACE syndrome. Br J Dermatol 2011; 164: 886-888.
18. Oranje AP, et al: Treatment of small superficial HOI with timolol 0.1% gel or 0.5% ophthalmic solution. Dutch Ned T Derm Venereol 2010; 711:711-713.
19. Janmohamed SR, de Waard-van der Spek FB, Madern GC, de Laat PCJ, Oranje AP: Scoring the proliferative activity of haemangioma of infancy: the Haemangioma Activity Score (HAS). Clin Exp Dermatol 2011; 36: 715-723.
20. Janmohamed SR, de Laat PCJ, Madern GC, Oranje AP: Do we have to check glucose in patients with haemangioma of infancy treated with beta-blockers? J Eur Acad Dermatol Venereol 2011, E-pub ahead of print.
21. Sorrell J, Carmichael C, Chamlin S: Oral sucrose for pain relief in young infants with hemangiomas treated with intralesional steroids. Pediatr Dermatol 2010; 27: 154-155.
22. Mishra D, Garg M, Dubey V, et al: Elastic lipsomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride. J Pharm Sci 2007; 96: 145-155.
23. Jappe U, Uter W, Menezes de Pádua CA, Herbst RA, Schnuch A: Allergic contact dermatitis due to beta-blockers in eye drops: a retrospective analysis of multicentre surveillance data 1993-2004. Acta Derm Venereol 2006; 86: 509-514.
24. Valsecchi R, Leighissa P, Piazzolla S, et al: Occupational contact dermatitis from propranolol. Contact Dermatitis 1994; 30: 177.